Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer
Á Pinto - Cancer biology & therapy, 2014 - Taylor & Francis
Prostate cancer is a heterogeneous disease where the previous concept of “hormone
resistance” has been changed by a new generation of hormonal therapies that have proven …
resistance” has been changed by a new generation of hormonal therapies that have proven …
Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer
Á Pinto - Cancer biology & therapy, 2014 - pubmed.ncbi.nlm.nih.gov
Prostate cancer is a heterogeneous disease where the previous concept of" hormone
resistance" has been changed by a new generation of hormonal therapies that have proven …
resistance" has been changed by a new generation of hormonal therapies that have proven …
[HTML][HTML] Beyond abiraterone: New hormonal therapies for metastatic castration-resistant prostate cancer
Á Pinto - Cancer Biology & Therapy, 2014 - ncbi.nlm.nih.gov
Prostate cancer is a heterogeneous disease where the previous concept of “hormone
resistance” has been changed by a new generation of hormonal therapies that have proven …
resistance” has been changed by a new generation of hormonal therapies that have proven …
Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer.
Á Pinto - Cancer Biology & Therapy, 2013 - europepmc.org
Prostate cancer is a heterogeneous disease where the previous concept of “hormone
resistance” has been changed by a new generation of hormonal therapies that have proven …
resistance” has been changed by a new generation of hormonal therapies that have proven …